World Anti Doping Agency (WADA) on Monday released a list of substances and methods that are prohibited in 2020.
The list constitutes Anabolic agents like androgenic steroids, peptide hormones, growth factors, and mimetics like Erythropoietin (EPO), beta-2 agonists including all optical isomers like Fenoterol and Formoterol.
The presence in urine of salbutamol in excess of 1000 ng/mL or formoterol in excess of 40 ng/mL is not consistent with therapeutic use of the substance and will be considered as an Adverse Analytical Finding (AAF) unless the Athlete proves, through a controlled pharmacokinetic study, that the abnormal result was the consequence of a therapeutic dose (by inhalation) up to the maximum dose indicated above.
The list also barred hormone and metabolic modulators, diuretics and masking agents, as well as other substances with a similar chemical structure or similar biological effects.
All-natural and synthetic cannabinoids are prohibited, glucocorticoids are prohibited when administered by oral, intravenous, intramuscular or rectal routes.
WADA's compliance review committee (CRC) had suggested several sanctions because of the Russian Anti-Doping Agency's (RUSADA) failure to cooperate fully during probes into Russian sport, CNN had reported.
WADA's executive committee decided to uphold the recommendations at a meeting in Lausanne, Switzerland.
It is being alleged that Russia manipulated a database to delete some test results and fabricate other data.
Three years ago, Russia was caught in one of the most controversial doping programs in sports history.
In the program, Russian anti-doping experts and members of the country's intelligence service replaced urine samples tainted by performance-enhancing drugs with clean urine at the 2014 Winter Olympics in Sochi, Russia.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
